Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 748 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Preterm Labor, Premature Birth Clear all

Conditions: Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth
Interventions: Ceftriaxone 1000 MG, Clarithromycin 500mg, Metronidazole 500 mg, Ampicillin 2 GM Injection, Amoxicillin 250 MG, Azithromycin, Erythromycin; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Columbus, Ohio • Galveston, Texas

Conditions: Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia, Preterm Birth
Interventions: Pacifier Activated Lullaby ®; Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 1 Day to 33 Weeks
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Preterm Birth, Preterm Delivery
Interventions: Fitbit activity tracker; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Infant,Premature
Interventions: Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, Magnetic Resonance Imaging; Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 35 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Respiratory Syncytial Virus Hospitalizations
Interventions: Not listed
Lead sponsor: AstraZeneca; Industry
Eligibility: Up to 12 Months
Enrollment: 497 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 44
States / cities: Little Rock, Arkansas • Loma Linda, California • Long Beach, California + 40 more

Conditions: Atopy, Prematurity
Interventions: microbiome pattern; Other
Lead sponsor: Sydney Leibel; Other
Eligibility: 0 Days to 7 Days
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2030
U.S. locations: 2
States / cities: San Diego, California

Conditions: Premature Infants
Interventions: cholecalciferal, cholecalciferol; Dietary Supplement
Lead sponsor: University of Nebraska; Other
Eligibility: 23 Weeks to 32 Weeks
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Preterm Delivery
Interventions: Not listed
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Language Development, Premature Infant, Neurodevelopmental Outcomes
Interventions: Know Your Baby Language Curriculum, Reading Aloud Language Curriculum, Sing A Long Language Curriculum, Mimicking First Sounds Language Curriculum, Language Games and Narrating Your Day Language Curriculum, Feeding Safety, Car Seat Safety, Bath Safety, Back to Sleep/SIDS prevention, Taking a Temperature and Signs of Infection, Infection Control Measures and Vaccine Information; Other
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 23 Weeks to 32 Weeks
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Preterm Delivery, Inadequate Milk Production
Interventions: Merotocin, Placebo; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 10
States / cities: New Haven, Connecticut • South Bend, Indiana • Baltimore, Maryland + 7 more

Conditions: Bronchopulmonary Dysplasia, Respiratory Distress Syndrome, Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
Interventions: Minimal mechanical ventilation management, Routine mechanical ventilation management, Dexamethasone, Placebo; Procedure · Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 5 Minutes to 10 Days
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2002
U.S. locations: 13
States / cities: Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 10 more

Conditions: Respiratory Distress Syndrome, Intraventricular Hemorrhage, Neonatal Mortality
Interventions: Betamethasone(Celestone soluspan) and Dexamethasone; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Sepsis, Length of Stay, Mortality, Neurodevelopmental Delay
Interventions: Limited Trophic Feeds (1 day of trophic feeds), Extended Trophic Feeds (3 days of trophics); Other
Lead sponsor: University of Washington; Other
Eligibility: 0 Years to 2 Years
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2031
U.S. locations: 6
States / cities: Birmingham, Alabama • Tampa, Florida • Oklahoma City, Oklahoma + 3 more

Conditions: Prematurity; Extreme, Feeding Patterns, Ventilator Lung; Newborn
Interventions: Continuous Feeds, Intermittent Bolus Feeds; Other
Lead sponsor: Rajeev Kumar; Government
Eligibility: Not listed
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Intraventricular Brain Hemorrhage
Interventions: Not listed
Lead sponsor: Electrical Geodesics, Inc.; Industry
Eligibility: 30 Weeks to 34 Weeks
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Gainsville, Florida

Conditions: Transient Tachypnea of the Newborn
Interventions: Amount of total fluids; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: Up to 24 Hours
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Newborn, Birth, Preterm
Interventions: OxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System, LNCS® NEO SpO2 Sensor with RAD-97™ Pulse CO-Oximeter, 1041PTS (or similar) Kendall™ Neonatal Electrodes with IntelliVue MP5 Portable Patient Monitor; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 29 Weeks and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Los Angeles, California • St Louis, Missouri • Winston-Salem, North Carolina

Conditions: Preeclampsia, Eclampsia, HELLP Syndrome, Toxemia, Hypertensive Disorder of Pregnancy
Interventions: Not listed
Lead sponsor: Preeclampsia Foundation; Other
Eligibility: 13 Years and older
Enrollment: 20,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2040
U.S. locations: 1
States / cities: Melbourne, Florida

Conditions: Preterm Delivery
Interventions: Not listed
Lead sponsor: Obstetrix Medical Group; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 995 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 10
States / cities: Mesa, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 7 more

Conditions: Obstetric Labour, Premature
Interventions: Retosiban solution for Infusion, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 20 Years to 45 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Glendale, California

Conditions: Acute Kidney Injury, Premature Infant
Interventions: Near Infrared Spectroscopy; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 1 Minute to 7 Days
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Preterm Birth
Interventions: Not listed
Lead sponsor: Sera Prognostics, Inc.; Industry
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 5,011 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 18
States / cities: Phoenix, Arizona • Orange, California • San Diego, California + 15 more

Conditions: Preterm Birth, Premature Rupture of Membranes
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: Not listed
Enrollment: 6,838 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2016
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Premature Birth, Premature Infant, Premature, Intrauterine Growth Restriction, Small for Gestational Age at Delivery
Interventions: PEAPOD Infant Body Composition measuring device; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 22 Weeks to 32 Weeks
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

PAL to Improve Oral Feeding for Infants With Chronic Lung Disease

Fitbit Activity Tracker to Predict Risk of Preterm Birth

Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI)

An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants

Microbiome, Atopic Disease, Prematurity

Serum 25-hydroxy Vitamin D [25(OH)D] Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants

Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery

NICU Parent Education Program

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)

Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"

Limited Versus Extended Trophic Feeding (LET-FEED) Trial

To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation.

Detection and Quantification of Neonatal Intraventricular Hemorrhage

Fluid Management in Transient Tachypnea of the Newborn

Pulse Oximetry Performance Comparison in Newborns

The Preeclampsia Registry

Neonatal Outcome by Reason for Delivery

Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women

NIRS Monitoring to Detect AKI in Preterm Infants

A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor

Microarray Expression Profiling to Identify Stereotypic mRNA Profiles in Human Parturition

Growing Little PEAPODS Study